Assay.Works and 2bind are partnering to expand the range of discovery services provided for companies in the pharmaceutical and biotech industry, and academic organizations.
NanoTemper Technologies Gmbh has scored custom from the UK CRO Domainex Ltd., which is using its MicroScale Thermophoresis technology for speedier, “higher quality clinical candidates”.
reMYND NV is to offer the A4 amyloid testing service to support preclinical screening of Alzheimer’s treatments after inking a deal with Amorfix Life Sciences.
MDS Analytical Technologies has followed its acquisition of
Molecular Devices last year by snapping up high content screening
(HCS) experts Blueshift for $15m (€9.45m).
Varian, Invitrogen, BMG Labtech and Hosokawa Micron have all
recently announced new product launches, detailing a selection of
tools and equipment to aid the scientist working in the laboratory
environment.
LabTechnologist.com brings you a round up of the latest product
news and releases from Agilent, Caliper, Grabner, Micronic,
Millipore, Torrey Pines and Warner.
BioTrove and Blue Sky Biotech announce a collaborative effort to
provide a unique service solution, utilising mass
spectrometry-based high-throughput screening assays on previously
unscreenable drug targets.
New data that shows the effectiveness of TTP LabTech's Acumen
Explorer for high content screening at high throughput reveals the
advances high content screening has made in applications such as
protein kinase activation, cell...
Thermo have introduced, what it claims is the next generation of
high content screening (HCS), launching a compact system that has a
small footprint, which frees up valuable lab floor space. The
product additionally offers turnkey...
The importance of high-throughput screening and human microdosing
during clinical trial processes has highlighted an emerging trend
in drug R&D that uses smaller and smaller test volumes, helped
by sophisticated automation technologies...
Molecular Devices launches two new reagent products for ADME assay
screening, which provide high throughput screening laboratories
with biologically relevant solutions to increase the throughput of
ADME-related compound profiling.
Cybio has launched a new flash luminescence reader that improves
throughput and data quality in functional screening of G-Protein
coupled receptors and calcium channels in drug discovery and
research.
Cell-based assays are set to become the preferred choice of
screening, potentially overtaking more traditional approaches that
include traditional enzyme- or antibody-based assays.
A worldwide non-exclusive co-development and marketing agreement
has been formed between Definiens and BioImage with the aim of
delivering tailored applications to the high content screening
(HCS) market.
Caliper Life Sciences' LabChip technology continues to prove
popular with large pharmaceutical companies as its third quarter
financial results show a net loss that has more than halved from
its 3Q 2003 performance.
Constant innovation in the field of microfluidics and uTAS has
enabled lab-on-a-chip (LOC) technologies to successfully enter the
mainstream commercial market especially impacting on
high-throughput screening of drug candidates, point...
Tecan has launched the Freedom EVO 96R and EVO 384R, two new
integrated multi-channel pipetting platforms for liquid handling
applications. These systems will be presented at the "Drug
Discovery Technology" exhibition in...
Tecan of Switzerland's US subsidiary has launched Cellerity, a new
system designed to produce a ready supply of cells for cell-based
assays, at the LabAutomation 2004 exhibition, which opened its
doors yesterday.
The worldwide cellular assays market is projected to grow by more
than 50 per cent to $700 million over the next five years as
pharmaceutical and biotechnology companies seek methods to increase
the efficiency of their drug discovery...
Just ahead of the Lab Automation Europe and International Biotech
conferences in London this week, DrugResearcher.com spoke with
Kevin Hrusovsky, the chief executive of Caliper Technologies, to
get his take on the current state of...
Evotec OAI once again defied the difficult environment for drug
discovery technology companies with a 20 per cent hike in
nine-month revenues to €56.7 million. Growth was driven by the
firm's ultra high-throughput screening collaboration...
An escalation in drug discovery activities in the Asia Pacific
region is likely to cause significant growth for technologies used
in high-throughput screening, according to a new report from Frost
& Sullivan.
An escalation in drug discovery activities in the Asia Pacific
region is likely to cause significant growth there for technologies
used in high-throughput screening, according to a new report.
Next week's Society for Biomolecular Screening annual meeting will
once again be a showcase for dozens of new products in the drug
discovery arena. We preview some of the highlights.
Iceland's deCODE genetics has initiated high-throughput screening
on its Neuregulin 1 pathway targets in schizophrenia in
collaboration with partner Roche.
